Eugene

[email protected]

LATEST

Roivant’s Dermavant Sciences To Buy Investigational Drug From GSK
By

By
GlaxoSmithKline (GSK) has agreed to sell the rights to its investigational drug, tapinarof, to Dermavant Sciences, the dermatology subsidiary of Roivant Sciences, a Basel, Switzerland globally headquartered biopharmaceutical company, for…

FDA Forms New Drug Shortages Task Force
By

By
The US Food and Drug Administration (FDA) has formed a new Drug Shortages Task Force that will be led by Keagan Lenihan, the FDA’s Associate Commissioner for Strategic Initiatives. The…

Teva Among Three Companies with Voluntary Recall of Valsartan-Containing Products
By

By
The US Food and Drug Administration (FDA) has announced a voluntary recall of several drug products containing the active ingredient, valsartan, which is used to treat high blood pressure and…

Valeant Pharmaceuticals Completes Name Change to Bausch Health Companies
By

By
Valeant Pharmaceuticals International has completed the change of its company name to Bausch Health Companies, as previously announced in May 2018. The new name is taken from its subsidiary, Bausch…

Genmab, Immatics in $2.8-Billion Deal for Immunotherapies
By

By
Genmab A/S, a Copenhagen, Denmark-based biopharmaceutical company developing therapeutic anti-cancer antibodies, has formed a license pact with Immatics Biotechnologies GmbH, a Tuebingen, Germany-based clinical-stage biopharmaceutical company, to discover and develop…

Otsuka To Acquire Precision Antibody Specialist Visterra for $430 Million
By

By
Otsuka Pharmaceutical has agreed to acquire Visterra, a Waltham, Massachusetts-headquartered clinical-stage biopharmaceutical company focused on antibody development, for approximately $430 million in cash. Both companies’ Board of Directors have approved…

Pfizer To Reorganize Into Three Businesses
By

By
Pfizer has announced plans to reorganize the company into three businesses; an Innovative Medicines business, an Established Medicines business, and a Consumer Healthcare business. These changes will be effective at…

Catalent Adopts Optofluidic Platform for Cell-Line Development
By

By
Catalent Pharma Solutions plans to adopt an optofluidic platform for cell-line development provided by Berkeley Lights (BLI), an Emeryville, California-headquartered company developing platforms for biopharmaceutical processes. BLI’s Beacon optofluidic platform…

Ajinomoto, Filament BioSolutions in Supply Pact
By

By
Filament BioSolutions, a New York-headquartered development-stage therapeutics company, has formed a collaboration with Ajinomoto Co., a Tokyo, Japan-based manufacturer of amino acids, to develop Filament’s lead product, FB-2710, an oral…

EMA Initiates EU Recall of Valsartan from Chinese Pharma Company
By

By
The European Medicines Agency (EMA) has initiated a recall of the active substance, valsartan, supplied by Zhejiang Huahai Pharmaceuticals, a Linhai, China-based pharmaceutical company. As the substance is being recalled,…